Go Pro
→ The 1934 playbook (From American Alternative) (Ad)tc pixel Free NAII Stock Alerts

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$2.28 +0.08 (+3.39%)
As of 02:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NAII vs. UPXI, INKT, INCR, ABVC, and TIL

Should you buy Natural Alternatives International stock or one of its competitors? MarketBeat compares Natural Alternatives International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natural Alternatives International include Upexi (UPXI), MiNK Therapeutics (INKT), InterCure (INCR), ABVC BioPharma (ABVC), and Instil Bio (TIL). These companies are all part of the "pharmaceutical products" industry.

How does Natural Alternatives International compare to Upexi?

Upexi (NASDAQ:UPXI) and Natural Alternatives International (NASDAQ:NAII) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Upexi currently has a consensus price target of $8.10, suggesting a potential upside of 838.59%. Given Upexi's stronger consensus rating and higher possible upside, research analysts clearly believe Upexi is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Upexi
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Natural Alternatives International has higher revenue and earnings than Upexi. Upexi is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Upexi$15.81M4.30-$13.68M-$0.62N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

In the previous week, Natural Alternatives International had 3 more articles in the media than Upexi. MarketBeat recorded 4 mentions for Natural Alternatives International and 1 mentions for Upexi. Upexi's average media sentiment score of 1.87 beat Natural Alternatives International's score of 0.60 indicating that Upexi is being referred to more favorably in the media.

Company Overall Sentiment
Upexi Very Positive
Natural Alternatives International Positive

Upexi has a beta of -0.29, indicating that its share price is 129% less volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market.

Natural Alternatives International has a net margin of -10.13% compared to Upexi's net margin of -874.00%. Natural Alternatives International's return on equity of -12.21% beat Upexi's return on equity.

Company Net Margins Return on Equity Return on Assets
Upexi-874.00% -66.70% -19.56%
Natural Alternatives International -10.13%-12.21%-5.30%

5.7% of Upexi shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 9.0% of Upexi shares are held by insiders. Comparatively, 20.8% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Natural Alternatives International beats Upexi on 10 of the 16 factors compared between the two stocks.

How does Natural Alternatives International compare to MiNK Therapeutics?

Natural Alternatives International (NASDAQ:NAII) and MiNK Therapeutics (NASDAQ:INKT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

In the previous week, Natural Alternatives International had 2 more articles in the media than MiNK Therapeutics. MarketBeat recorded 4 mentions for Natural Alternatives International and 2 mentions for MiNK Therapeutics. MiNK Therapeutics' average media sentiment score of 1.31 beat Natural Alternatives International's score of 0.60 indicating that MiNK Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natural Alternatives International
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiNK Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MiNK Therapeutics has lower revenue, but higher earnings than Natural Alternatives International. MiNK Therapeutics is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A
MiNK TherapeuticsN/AN/A-$12.49M-$2.84N/A

32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 2.9% of MiNK Therapeutics shares are held by institutional investors. 20.8% of Natural Alternatives International shares are held by company insiders. Comparatively, 20.4% of MiNK Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

MiNK Therapeutics has a consensus target price of $35.00, suggesting a potential upside of 211.67%. Given MiNK Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe MiNK Therapeutics is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
MiNK Therapeutics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

MiNK Therapeutics has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. MiNK Therapeutics' return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Alternatives International-10.13% -12.21% -5.30%
MiNK Therapeutics N/A N/A -118.57%

Natural Alternatives International has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, MiNK Therapeutics has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market.

Summary

MiNK Therapeutics beats Natural Alternatives International on 9 of the 16 factors compared between the two stocks.

How does Natural Alternatives International compare to InterCure?

Natural Alternatives International (NASDAQ:NAII) and InterCure (NASDAQ:INCR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

InterCure has lower revenue, but higher earnings than Natural Alternatives International. Natural Alternatives International is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A
InterCure$78.47M0.67-$10.37M$0.0332.07

Natural Alternatives International has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, InterCure has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
InterCure
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

InterCure has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. InterCure's return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Alternatives International-10.13% -12.21% -5.30%
InterCure N/A N/A N/A

32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 8.3% of InterCure shares are held by institutional investors. 20.8% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Natural Alternatives International had 2 more articles in the media than InterCure. MarketBeat recorded 4 mentions for Natural Alternatives International and 2 mentions for InterCure. InterCure's average media sentiment score of 1.45 beat Natural Alternatives International's score of 0.60 indicating that InterCure is being referred to more favorably in the news media.

Company Overall Sentiment
Natural Alternatives International Positive
InterCure Positive

Summary

InterCure beats Natural Alternatives International on 9 of the 13 factors compared between the two stocks.

How does Natural Alternatives International compare to ABVC BioPharma?

ABVC BioPharma (NASDAQ:ABVC) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ABVC BioPharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

ABVC BioPharma has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, suggesting that its share price is 64% less volatile than the broader market.

In the previous week, Natural Alternatives International had 3 more articles in the media than ABVC BioPharma. MarketBeat recorded 4 mentions for Natural Alternatives International and 1 mentions for ABVC BioPharma. ABVC BioPharma's average media sentiment score of 1.89 beat Natural Alternatives International's score of 0.60 indicating that ABVC BioPharma is being referred to more favorably in the media.

Company Overall Sentiment
ABVC BioPharma Very Positive
Natural Alternatives International Positive

ABVC BioPharma has higher earnings, but lower revenue than Natural Alternatives International. ABVC BioPharma is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ABVC BioPharma$510K66.27-$7.91M-$0.40N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

11.4% of ABVC BioPharma shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 19.0% of ABVC BioPharma shares are owned by company insiders. Comparatively, 20.8% of Natural Alternatives International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ABVC BioPharma has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat ABVC BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
ABVC BioPharmaN/A -62.46% -39.99%
Natural Alternatives International -10.13%-12.21%-5.30%

Summary

Natural Alternatives International beats ABVC BioPharma on 7 of the 13 factors compared between the two stocks.

How does Natural Alternatives International compare to Instil Bio?

Instil Bio (NASDAQ:TIL) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Natural Alternatives International has higher revenue and earnings than Instil Bio. Instil Bio is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Instil BioN/AN/A-$71.37M-$7.08N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

Instil Bio has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat Instil Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Instil BioN/A -39.76% -22.38%
Natural Alternatives International -10.13%-12.21%-5.30%

In the previous week, Natural Alternatives International had 3 more articles in the media than Instil Bio. MarketBeat recorded 4 mentions for Natural Alternatives International and 1 mentions for Instil Bio. Instil Bio's average media sentiment score of 1.87 beat Natural Alternatives International's score of 0.60 indicating that Instil Bio is being referred to more favorably in the media.

Company Overall Sentiment
Instil Bio Very Positive
Natural Alternatives International Positive

Instil Bio has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market.

Instil Bio currently has a consensus price target of $66.00, suggesting a potential upside of 762.86%. Given Instil Bio's stronger consensus rating and higher possible upside, equities research analysts plainly believe Instil Bio is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Instil Bio
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

60.6% of Instil Bio shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 47.0% of Instil Bio shares are owned by company insiders. Comparatively, 20.8% of Natural Alternatives International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Instil Bio and Natural Alternatives International tied by winning 7 of the 14 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

Export
MetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$14.35M$2.99B$6.78B$12.65B
Dividend YieldN/A2.08%2.68%8.43%
P/E Ratio-0.9619.3827.1324.40
Price / Sales0.11344.38525.2891.46
Price / CashN/A56.8348.5959.39
Price / Book0.214.2510.856.33
Net Income-$13.57M$65.13M$3.59B$331.45M
7 Day Performance0.22%-2.46%-1.34%0.18%
1 Month Performance-9.33%2.22%2.96%-0.72%
1 Year Performance-33.19%23.71%28.93%20.53%

Natural Alternatives International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0.5825 of 5 stars		$2.29
+3.4%		N/A-35.0%$14.35M$129.86MN/A290
UPXI
Upexi
2.5658 of 5 stars		$0.81
-3.1%		$8.10
+906.2%		-86.0%$55.44M$15.81MN/A130
INKT
MiNK Therapeutics
2.7679 of 5 stars		$10.85
+2.2%		$35.00
+222.6%		-71.9%$54.03MN/AN/A30
INCR
InterCure
1.3544 of 5 stars		$0.98
+1.6%		N/A-36.1%$53.59M$78.47M32.67350
ABVC
ABVC BioPharma
1.0081 of 5 stars		$2.03
+0.5%		N/A-61.8%$53.30M$510KN/A30

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAII) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel